You have 9 free searches left this month | for more free features.

Etoposide phosphate

Showing 26 - 50 of 1,776

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

Recruiting
  • Desmoplastic Small Round Cell Tumor
  • +11 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 26, 2022

Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

Active, not recruiting
  • Disseminated Neuroblastoma
  • +5 more
  • Birmingham, Alabama
  • +22 more
Mar 3, 2022

Medulloblastoma, Pineoblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified Trial in United States (radiation, drug,

Completed
  • Medulloblastoma
  • +2 more
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Los Angeles, California
  • +14 more
Jan 12, 2022

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • HLX10 + chemotherapy (carboplatin-etoposide)
  • Atezolizumab + chemotherapy (carboplatin-etoposide)
  • (no location specified)
Jul 19, 2022

Classic Hodgkin's Lymphoma Trial in Beijing (Sintilimab, Carboplatin, Etoposide)

Recruiting
  • Classic Hodgkin's Lymphoma
  • Sintilimab
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 12, 2022

ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

Recruiting
  • ENSAT Stage I Adrenal Cortex Carcinoma
  • +2 more
  • Ann Arbor, Michigan
  • +3 more
Dec 13, 2022

Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor Trial in United States (biological,

Active, not recruiting
  • Ovarian Granulosa Cell Tumor
  • +6 more
  • Bleomycin Sulfate
  • +5 more
  • Anchorage, Alaska
  • +218 more
Dec 30, 2021

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2023

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

Active, not recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Duarte, California
  • +3 more
Oct 24, 2022

Multiple Myeloma, Plasma Cell Tumor Trial in Tampa (etoposide phosphate, melphalan, topotecan)

Completed
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • etoposide phosphate
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 6, 2019

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023

Double-Expressor Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements, High Grade B-Cell Lymphoma

Not yet recruiting
  • Double-Expressor Lymphoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Houston (drug,

Recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

Recruiting
  • Acute Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Atlanta, Georgia
  • +13 more
Jan 26, 2023

Small Cell Lung Cancer Extensive Stage Trial in Spain (Lenvatinib, Pembrolizumab, Etoposide)

Recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Badalona, Barcelona, Spain
  • +17 more
Jan 26, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Jacksonville, Florida
  • +11 more
Jan 12, 2023

Carcinoma, Small Cell Trial in Canada, United States (Pomalidomide, Cisplatin, Etoposide)

Terminated
  • Carcinoma, Small Cell
  • Cleveland, Ohio
  • +5 more
Nov 6, 2019

Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)

Completed
  • Lymphoma
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Small Cell Lung Carcinoma Trial in Omaha (Durvalumab + Tremelimumab in combination with carboplatin and etoposide, Durvalumab in

Terminated
  • Small Cell Lung Carcinoma
  • Durvalumab + Tremelimumab in combination with carboplatin and etoposide
  • Durvalumab in combination with carboplatin and etoposide
  • Omaha, Nebraska
    University of Nebraska Medical Center
Feb 24, 2022